The world could be closer to a vaccine against HIV, according to research released Monday by the National Institutes of Health.According to a news release from NIH, results from an early-stage clinical trial called APPROACH "show that an investigational HIV vaccine regimen was well-tolerated and generated immune responses against HIV in healthy adults.